Why the Painchek (ASX:PCK) share price lifted today

The Painchek (ASX: PCK) share price was up more than 4% at close of trade after the company released its quarterly report today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Painchek Ltd (ASX: PCK) share price climbed today after the company provided the market with a positive quarterly update for December 2020.

Shares in the small cap healthcare company were trading 4.2% higher at 7.4 cents on close of trade today.

medical asx share price represented by doctor giving thumbs up

Image source: Getty Images

What is driving the Painchek share price

In today's release, the company reported continued growth in its aged care and initial entry into the hospital, home care and disability markets during the quarter ended 31 December.

In its core aged care market segment, Painchek delivered sales growth of 7% from the prior quarter. And with its global licences covering 71,318 beds, year on year (YoY) growth is up 123%. The company reported its domestic sales now reflect more than 30% of Australia's domestic aged care market share.

As a result, Painchek now has 884 aged care clients, up 133% YoY, and the forward looking revenue equates to more than $3 million annualised recurring revenue.

However it was not all smooth sailing for the company, with several large provider agreements delayed as a result of COVID-19 disruptions. Paincheck said these discussions have since been resumed in January.

Management comments

Painchek CEO Philip Daffas welcomed the update, saying:

While 2020 was challenging for many businesses, we successfully continued to deliver with significant sales growth. This included pivoting to a fully digital sales and delivery model that met the immediate needs of our clients, as well as establishing a new cost-effective global go-to-market model.

About the company

PainChek develops and commercialises medical device applications. This is aimed specifically at automating intelligent pain assessment of individuals who are unable to communicate their pain with carers (such as people in aged care facilities).

In particular, the company is involved in the provision of pain management and better medication for residents living with dementia and other communication difficulties. Painchek has already obtained regulatory clearance in Australia and Europe.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough end to a tough week.

Read more »

Graphic showing yellow arrow above vertical columns indicating a rising share price
Share Market News

$10,000 invested in this ASX ETF a month ago is now worth $14,500

Investors in this ASX ETF are sitting on very appealing short-term gains.

Read more »

Businessman looks with one eye through magnifying glass.
Share Market News

Pulse check: How are the top 10 ASX 200 shares performing amid a new war?

What's happening with CBA, BHP, Wesfarmers, Woodside, Telstra, and other large-cap shares?

Read more »

Happy man working on his laptop.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

3 buy-rated ASX shares in today's falling market

The market is now 4% down in 2026, but amid the volatility, experts say there are good buys available.

Read more »

three young children weariing business suits, helmets and old fashioned aviator goggles wear aeroplane wings on their backs and jump with one arm outstretched into the air in an arid, sandy landscape.
Share Gainers

3 ASX 200 stocks screaming higher in this week's sinking market

Investors sent these three ASX 200 stocks surging this week despite the broader market retrace. But why?

Read more »

Person with thumbs down and a red sad face poster covering the face.
Share Fallers

Why EOS, Latitude, Northern Star, and Rio Tinto shares are falling today

These shares are ending the week in the red. But why?

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Share Gainers

Guess which ASX lithium share is leaping 14% in Friday's sinking market

Investors are piling into this small-cap ASX lithium miner today. But why?

Read more »